Top

Published in:

01-06-2010 | Editorial

Botulinum toxin and urinary bladder disorders in women: new insight into an old problem

Authors: Ervin Kocjancic, Diaa E. E. Rizk

Published in: International Urogynecology Journal | Issue 6/2010

Excerpt

“…and the urinary bladder; this also may be plainly observed to receive and accumulate fluid until it is so stretched by the amount of this and to be incapable of enduring the pain; or it may be the quality of urine that irritates it”.

Claudius Galen, On the Natural Faculties, 180–190 A.D.

…

Beer K, Kellner E, Beer J (2009) Cosmeceuticals do rejuvenation. Facial Plast Surg 25:285–289CrossRefPubMed

Dykstra DD, Sidi AA, Scott AB, Pagel JM, Goldfish GD (1988) Effects of botulinum A toxin on detrusor–sphincteric dyssynergia in spinal cord injury patients. J Urol 139:919–922PubMed

Apostolidis A, Dasgupta P, Fowler CJ (2006) Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 49:644–650CrossRefPubMed

Diokno A, Sand P, Labasky R (2002) Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of participants with overactive bladder: a one-year study. Int Urol Nephrol 34:43–49CrossRefPubMed

Schurch B, Stoher M, Kramer G, Schmid DM, Gaul G, Hauri D (2000) Botulinum A toxin for treating detrusor hyper-reflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164:692–697CrossRefPubMed

Stoehrer M, Wolff A, Kramer G et al (2009) Treatment of neurogenic detrusor overactivity with botulinum toxin A: the first seven years. Urol Int 83:379–385CrossRefPubMed

Reitz A, Stohrer M, Kramer G (2004) European experience of 200 cases treated with botulinum A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45:510–515CrossRefPubMed

Apostolidis A, Dasgupta P, Denys P et al (2009) Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunction: a European Consensus Report. Eur Urol 55:100–120CrossRefPubMed

Schurch B, Hauri D, Rodic B, Curt A, Meyer M, Rossier AB (1996) Botulinum A toxin as a treatment of detrusor–sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 155:1023–1029CrossRefPubMed

10.

Kocjancic E (2007) Botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence. Eur Urol 52:858–859CrossRefPubMed

11.

Comperat E, Reitz A, Delcourt A, Capron F, Denys P, Chartier KE (2006) Histological features in the urinary bladder wall affected from neurogenic overactivity—a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A. Eur Urol 50:1058–1064CrossRefPubMed

12.

Patterson JM, Chapple CR (2006) Botulinum toxin in urinary incontinence. Curr Opin Urol 16:255–260CrossRefPubMed

13.

Gupta M, Patel T, Xavier K et al (2010) Prospective randomized evaluation of periureteral botulinum toxin type A injection for ureteral stent pain reduction. J Urol 183:598–602CrossRefPubMed

14.

Smith CP, Radziszewski P, Borkowski A, Somogyi GT, Boone TB, Chancellor MB (2004) Botulinum toxin A has antinociceptive effects in treating interstitial cystitis. Urology 64:871–875CrossRefPubMed

15.

Kuo H (2005) Preliminary results of suburothelial injection of botulinum A toxin in the treatment of chronic interstitial cystitis. Urol Int 75:170–174CrossRefPubMed

16.

Campbell JD, Gries KS, Watanabe JH, Ravelo A, Dmochowski RR, Sullivan SD (2009) Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence. BMC 9:18

Title: Botulinum toxin and urinary bladder disorders in women: new insight into an old problem
Authors: Ervin Kocjancic
Diaa E. E. Rizk
Publication date: 01-06-2010
Publisher: Springer-Verlag
Published in: International Urogynecology Journal / Issue 6/2010
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-010-1136-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Botulinum toxin and urinary bladder disorders in women: new insight into an old problem

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2010

Patients of surgical educational course may have a poorer outcome for pelvic organ prolapse repair and higher complication rate: a case-control study in urogynecology

The adjustable tension-free vaginal tape—obturator

Midline fascial plication under continuous digital transrectal control: which factors determine anatomic outcome?

Long-term and short-term effects of simulated birth trauma, cesarean and vaginal delivery on sulfated glycosaminoglycans in the urethra of female rats

Iliosacral bacterial arthritis and retroperitoneal abscess after tension-free vaginal mesh reconstruction

Inpatient bladder retraining: is it beneficial on its own?